Keywords: IMS Health, MIDAS Biosimilars, Marketin measurement tool

IMS debuts MIDAS Biosimilars, a new market tool for fast-developing pharma segment

Article | 22 August 2011

IMS Health has launched IMS MIDAS Biosimilars, a market measurement tool that enables clients to assess the value of treatments ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in